Lisata extends Kuva Labs tender offer launch deadline to April 13

• Kuva Labs agreed with Lisata to extend deadline to commence tender offer for all outstanding Lisata common shares to April 13, 2026, from April 3, 2026.
• Purchaser has not yet commenced tender offer under merger agreement signed March 6, 2026.
• Parent is seeking alternative financing on terms more favorable to it to fund tender offer.
• Lisata remains in discussions with Parent on financing and timing for commencement.
• Timing for tender offer launch remains uncertain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-014775), on April 15, 2026, and is solely responsible for the information contained therein.